18620-02-5

Basic information

• Product Name: Magnesium, bromo(4-bromophenyl)-
• Synonyms: Magnesium, bromo(4-bromophenyl)-;4-Bromophenylmagnesium bromide, 0.50 M in THF;4-Bromophenylmagnesium bromide, 0.50 M in 2-MeTHF;4-Bromophenylmagnesium bromide
• CAS NO: 18620-02-5
• Molecular Formula: C₆H₄Br₂Mg
• Molecular Weight: 260.23
• Mol File: 18620-02-5.mol
• Article Data: 15

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Magnesium, bromo(4-bromophenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Magnesium, bromo(4-bromophenyl)-(18620-02-5)
• EPA Substance Registry System: Magnesium, bromo(4-bromophenyl)-(18620-02-5)

Safety Data

• Hazardous Substances Data: 18620-02-5(Hazardous Substances Data)

Usage

General Description

Magnesium, bromo(4-bromophenyl)- is a chemical compound with the molecular formula MgBrC6H4Br. It is a crystalline solid that is used as a reagent in organic synthesis and as a catalyst in various chemical reactions. Magnesium, bromo(4-bromophenyl)- is commonly used as a brominating agent in the synthesis of organic compounds, particularly in the pharmaceutical industry. It is also used in the production of flame retardants, dyes, and other industrial chemicals. Magnesium, bromo(4-bromophenyl)- has low acute toxicity but should be handled with care due to its corrosive and irritant properties.

Upstream product

• 106-37-6 1.4-dibromobenzene 
• 7439-95-4 magnesium 
• 1719-57-9 Chloro(chloromethyl)dimethylsilane 
• 95-92-1 oxalic acid diethyl ester 
• 2043-10-9 chloro-chloromethyl-dimethylsilane 

Downstream Products

• 4654-39-1 4-bromophenethanol 
• 100124-17-2 (4-bromo-phenyl)-[4]pyridyl ketone-imine 
• 2159-40-2 2-(4-bromobenzoyl)benzoic acid 
• 6999-03-7 1-bromo-4-(trimethylsilyl)benzene 
• 1585-07-5 1-bromo-4-ethylbenzene 
• 61623-62-9 1-(p-bromophenyl)-1,1-diphenylcarbinol 
• 2039-82-9 1-bromo-4-ethenyl-benzene 
• 18089-97-9 bis-(4-bromo-phenyl)-chloro-methyl-silane 
• 18141-19-0 (4-bromophenyl)(dichloro)(methyl)silane 
• 30314-45-5 1-(4-bromophenyl)-2,2-dimethylpropan-1-one 
• 41492-05-1 p-bromobutylbenzene 
• 857601-51-5 3-(p-bromophenyl)-4-(p-anisyl)-3-hexene 
• 96484-29-6 bis(4-bromophenyl)borinic acid 
• 6962-82-9 Di-p-bromphenylborinsaeure-2-amino-ethylester 

Relevant articles and documents

Fluorene-containing organic compound and application thereof on OLED (organic light emitting diode) device

The invention discloses a fluorene-containing organic compound and an application thereof on an OLED (organic light emitting diode) device. The organic compound has the structure shown in the generalformula (1). The compound has higher glass transition temperature and molecular heat stability, proper HOMO and LUMO energy levels and higher Eg, the photoelectric property of an OLED device can be effectively improved and the service life of the OLED device can be effectively prolonged through structure optimization of the device.

Copper-catalyzed difluoromethylation of β,γ-unsaturated carboxylic acids: An efficient allylic difluoromethylation

Not one but two! A new strategy for the regiospecific construction of compounds with allylic CF2H groups has been developed. The decarboxylative (phenylsulfonyl)difluoromethylation of β,γ- unsaturated carboxylic acids is catalyzed by a Lewis acid (CuCl 2·2 H2O), and the resulting product easily undergoes desulfonylation. Copyright

Anti-hypercholesterolemic biaryl azetidinone compounds

This invention provides cholesterol absorption inhibitors of Formula I: and the pharmaceutically acceptable salts thereof, wherein R12 is an alkyl, alkeny or alkynyl group mono- or poly-substituted with —OH, —COOH or a combination of —OH and —COOH, and R9 contains an alkyl, alkeny or alkynyl group substituted with a heterocyclic ring, amino or sulfonyl. The compounds are useful for lowering plasma cholesterol levels, particularly LDL cholesterol, and for treating atherosclerosis and preventing atherosclerotic disease events.